Karyopharm Reports Strong Third Quarter 2021 Financial Results and Provides Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Karyopharm Reports Strong Third Quarter 2021 Financial Results and Provides Business Highlights

Karyopharm Therapeutics (KPTI) Misses Q3 EPS by 2c

November 3, 2021 7:24 AM EDT

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q3 EPS of ($0.69), $0.02 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $26.7 million versus the consensus estimate of $25.8 million.

For earnings history and earnings-related data on Karyopharm Therapeutics (KPTI) click here.

... More